By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Agios Pharmaceuticals 

38 Sidney Street
2nd Floor
Cambridge  Massachusetts  02139-4169  U.S.A.
Phone: 617-649-8600 Fax: n/a


Company News
Agios (AGIO) Announces Data From Dose-Escalation Phase I Study Of AG-120 In Patients With IDH1 Mutant Positive Advanced Solid Tumors 11/9/2015 7:30:55 AM
Agios (AGIO) Reports Third Quarter 2015 Financial Results 11/5/2015 10:22:45 AM
Agios (AGIO) To Present New Data From Lead Programs At The 2015 American Society of Hematology Annual Meeting 11/5/2015 8:27:38 AM
Agios (AGIO) To Present At Credit Suisse 24th Annual Healthcare Conference On Tuesday, November 10 11/3/2015 10:38:34 AM
Agios (AGIO) To Webcast Conference Call Of Third Quarter 2015 Financial Results On November 5, 2015 10/29/2015 9:19:15 AM
Agios (AGIO) To Present Clinical Data From Ongoing AG-120 Phase I Trial In Advanced Solid Tumors At AACR-National Cancer Institute-EORTC 10/27/2015 7:39:45 AM
Agios (AGIO) Outlines Key Clinical Development & Research Strategies 10/16/2015 7:50:03 AM
Agios (AGIO) To Webcast R&D Day On October 16, 2015 10/8/2015 7:49:54 AM
Agios (AGIO) To Present At Leerink Partners Rare Disease Roundtable 9/24/2015 9:46:58 AM
Agios (AGIO) Reports Second Quarter 2015 Financial Results And Provides Updates On Clinical Development Progress 8/6/2015 10:40:26 AM